Provided by Tiger Fintech (Singapore) Pte. Ltd.

Inovio Pharmaceuticals

1.95
+0.0000
Pre-market: 2.000.0500+2.56%08:00 EDT
Volume:447.75K
Turnover:871.33K
Market Cap:70.39M
PE:-0.44
High:1.99
Open:1.95
Low:1.91
Close:1.95
Loading ...

INOVIO to Present at Upcoming Scientific Conferences

PR Newswire
·
07 Nov 2024

Inovio Pharmaceuticals Inc expected to post a loss of $1.15 a share - Earnings Preview

Reuters
·
06 Nov 2024

INOVIO to Report Third Quarter 2024 Financial Results on November 14, 2024

PR Newswire
·
06 Nov 2024

Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024 in One Oral Presentation and Three Poster Presentations

GlobeNewswire
·
05 Nov 2024

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
05 Nov 2024

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
02 Nov 2024

Inovio Pharmaceuticals Inc. Stock Remains Steady Wednesday, Still Outperforms Market

Dow Jones
·
31 Oct 2024

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
29 Oct 2024

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
26 Oct 2024

Inovio Pharmaceuticals Inc. Stock Remains Steady Wednesday, Still Outperforms Market

Dow Jones
·
24 Oct 2024

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
22 Oct 2024

BRIEF-Inovio Announces New Data At Scientific Conferences For Lead Candidate, INO-3107, As A Potential Treatment For RRP

Reuters
·
21 Oct 2024

Inovio’s INO-3107 shows efficacy in recurrent respiratory papillomatosis

TIPRANKS
·
21 Oct 2024

Inovio Pharmaceuticals Inc - 81% of Patients Experienced Fewer Surgical Interventions Post-Treatment With Ino-3107

THOMSON REUTERS
·
21 Oct 2024

Inovio Pharmaceuticals Inc - Ino-3107 Well Tolerated, Most Frequent AES Were Injection Site Pain and Fatigue

THOMSON REUTERS
·
21 Oct 2024

Inovio Announces New Data at Scientific Conferences for Lead Candidate, Ino-3107, as a Potential Treatment for Rrp

THOMSON REUTERS
·
21 Oct 2024